Filter
207
Filtered Results: 207
Text search:
Alonso,
J.
Featured
Recommendations
11
New Publications
31
Language
Document type
No document type
93
Guidelines
47
Studies & Reports
46
Manuals
9
Strategic & Response Plan
5
Training Material
4
Fact sheets
2
Situation Updates
1
Countries / Regions
Global
11
Latin America and the Carribbean
10
Russia
7
Paraguay
6
Africa
6
India
5
Mozambique
5
Tanzania
4
Brazil
4
Sierra Leone
3
Nigeria
3
Senegal
3
Ethiopia
3
Cameroon
3
Middle East and North Africa
3
Western and Central Europe
3
Zimbabwe
2
Zambia
2
Syria
2
Kenya
2
South Africa
2
Malawi
2
Peru
2
Bolivia
2
Venezuela
2
Spain
2
Burkina Faso
1
Congo, Democratic Republic of
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Ghana
1
Uganda
1
Haiti
1
Philippines
1
Nepal
1
Afghanistan
1
Germany
1
Rwanda
1
Sudan
1
Argentina
1
Eswatini/ Swaziland
1
Burundi
1
Ukraine
1
Colombia
1
Ecuador
1
Botswana
1
Angola
1
Madagascar
1
Lesotho
1
Chile
1
Yemen
1
West and Central Africa
1
Eastern Europe and Central Asia
1
Eastern Europe
1
North America
1
Tunisia
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
58
Clinical Guidelines
38
Public Health
14
Women & Child Health
13
Key Resources
4
Capacity Building
2
Pharmacy & Technologies
1
Toolboxes
Mental Health
41
COVID-19
26
HIV
20
NTDs
11
Planetary Health
10
TB
9
Rapid Response
6
Refugee
6
NCDs
6
Ebola
4
AMR
4
Disability
3
Global Health Education
2
Caregiver
2
Conflict
1
Pharmacy
1
Health Financing Toolbox
1
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage.
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage.
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов...
19 February 2021
The overall objective of this prospective meta-analyses (PMA) is to estimate the effect of anti-IL-6 therapy compared with usual care in hospitalized patients with suspected or confirmed COVID-19. The primary comparison is of the class effect of anti-IL-6 therapies. It will also es...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
African Journal of Emergency Medicine
Volume 11, Issue 1, March 2021, Pages 132-139
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Background paper 9
The Independent Panel for Pandemic Preparedness and Response
May 2021
For the primary health worker in a low/middle-income country (LMIC) setting, delivering quality primary care is challenging. This is often complicated by clinical guidance that is out of date, inconsistent and informed by evidence from high-income countries that ignores LMIC resource constraints and...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
La presente publicación describe un resumen de la evidencia científica disponible sobre el uso de Cloroquina e hidroxicloroquina, así como su profilaxis y tratamiento para COVID-19.
Esta publicación pertenece al compendio Publicaciones Minsa sobre COVID-19
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
Global Biodiversity Outlook (GBO) is the flagship publication of the Convention on Biological Diversity (CBD). It is a periodic report that summarizes the latest data on the status and trends of biodiversity and draws conclusions relevant to the further implementation of the Convention.
GBO-5 pro...
The World Health Organization and the Global Fund to Fight AIDS, Tuberculosis and Malaria are part of a group of agencies working together to accelerate progress towards the health-related SDGs through the Global Action Plan for Healthy Lives and Well-being for All. Understanding patterns of inequal...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Recommendations on the management of diabetes mellitis during the COVID-19 pandemic
